Pharmacokinetics of Olverembatinib in Participants With Hepatic Impairment
Pharmacokinetics of Olverembatinib in Participants With Hepatic Impairment
Recruiting · NCT07282093 · Registry updated 2025-12-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pharmacokinetics of Olverembatinib in Participants With Hepatic Impairment | Olverembatinib; Pharmacokinetic | Recruiting | Phase 1 | 2025-12-23 | NCT07282093 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ascentage Pharma Group Inc. | 30 |
| Guangzhou Healthquest Pharma Co., Ltd | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The First Affiliated Hospital of Suzhou Medical University | Suzhou | China | 1 |